Topical Collection on Scleroderma

ISSN: 1523-3774 (Print) 1534-6307 (Online)

In this topical collection (57 articles)

previous disabled Page of 3

  1. No Access

    Scleroderma (J Varga, Section Editor)

    Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

    Dustin A. Carlson, Monique Hinchcliff, John E. Pandolfino Article:475

  2. No Access

    Scleroderma (J Varga, Section Editor)

    Role of Cellular Senescence and NOX4-Mediated Oxidative Stress in Systemic Sclerosis Pathogenesis

    Sonsoles Piera-Velazquez, Sergio A. Jimenez Article:473

  3. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Personalized Medicine in Systemic Sclerosis: Facts and Promises

    Rucsandra Dobrota, Carina Mihai, Oliver Distler Article:425

  4. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Recent Advances in Understanding the Pathogenesis of Scleroderma-Interstitial Lung Disease

    Tan**a Akter, Richard M. Silver, Galina S. Bogatkevich Article:411

  5. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Quantitating Skin Fibrosis: Innovative Strategies and Their Clinical Implications

    Giuseppina Abignano, Francesco Del Galdo Article:404

  6. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Animal Models of Scleroderma: Current State and Recent Development

    Yoshihide Asano, Shinichi Sato Article:382

  7. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Scleroderma-Related Lung Disease: Are Adipokines Involved Pathogenically?

    Shannon Haley, Dilip Shah, Freddy Romero, Ross Summer Article:381

  8. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Update on Stem Cell Transplantation for Systemic Sclerosis: Recent Trial Results

    Kamran Naraghi, Jacob M. van Laar Article:326

  9. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Recent Developments in Diagnosis and Assessment of Morphea

    Sarah Nouri, Heidi Jacobe Article:308

  10. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities

    Tomoaki Iwayama, Lorin E. Olson Article:304

  11. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Management of Raynaud’s Phenomenon and Digital Ischemia

    Ariane L. Herrick Article:303

  12. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Epidemiology and Risk Factors for Pulmonary Hypertension in Systemic Sclerosis

    Aaliya Yaqub, Lorinda Chung Article:302

  13. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    Morphogen Pathways in Systemic Sclerosis

    Christian Beyer, Jörg H. W. Distler Article:299

  14. No Access

    SCLERODERMA (J VARGA, SECTION EDITOR)

    The Immune Pathogenesis of Scleroderma: Context Is Everything

    Matthew B. Greenblatt, Antonios O. Aliprantis Article:297

  15. Scleroderma (J Varga, Section Editor)

    Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs

    Roberta Goncalves Marangoni, Benjamin Korman, John Varga Article:79
    Download PDF (2918KB) View Article

  16. No Access

    Scleroderma (J Varga, Section Editor)

    Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches

    Hanlin Yin, Rui Li, Liang**g Lu, Qingran Yan Article:77

  17. No Access

    Scleroderma (J Varga, Section Editor)

    Calcinosis in Systemic Sclerosis: Updates in Pathophysiology, Evaluation, and Treatment

    Carrie Richardson, Anna Plaas, John Varga Article:73

  18. No Access

    Scleroderma (J Varga, Section Editor)

    Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives

    Pei-Suen Tsou Article:69

  19. No Access

    Scleroderma (J Varga, Section Editor)

    Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis

    George Hung, Valentina Mercurio, Steven Hsu… Article:68

  20. No Access

    Scleroderma (J Varga, Section Editor)

    Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions

    Silvia Bellando-Randone, Marco Matucci-Cerinic Article:65
previous disabled Page of 3